Search results for "Intestinal"

showing 10 items of 2024 documents

Aggressive Pharmacological Treatment for Reversing Malignant Bowel Obstruction

2004

Early and intensive pharmacological treatment not only may reduce gastrointestinal symptoms but also reverse malignant bowel obstruction. Fifteen consecutive advanced cancer patients with inoperable bowel obstruction received a combination of drugs including metoclopramide, octreotide, dexamethasone and an initial bolus of amidotrizoato. Recovery of intestinal transit was reported within 1-5 days in fourteen patients, who continued this treatment without presenting symptoms of bowel obstruction until death. This case series establishes that the combination of propulsive and antisecretive agents can act synergistically to allow a fast recovery of bowel transit without inducing unpleasant col…

AdultMalemedicine.medical_specialtyMetoclopramidemedicine.drug_classOctreotideGastroenterologyBolus (medicine)Gastrointestinal AgentsInternal medicineEdemamedicineHumansGeneral NursingDexamethasoneAgedPelvic NeoplasmsTerminal Carebusiness.industrydigestive oral and skin physiologyPalliative CareFecal impactionDrug SynergismRecovery of FunctionMiddle Agedmedicine.diseasedigestive system diseasesBowel obstructionDrug CombinationsAnesthesiology and Pain MedicineTreatment OutcomeAnesthesiaAbdominal NeoplasmsCorticosteroidAntiemeticsFemaleNeurology (clinical)medicine.symptombusinessIntestinal Obstructionmedicine.drug
researchProduct

Adhesive Small Bowel Obstruction: Predictive Factors of Lack of Response in Conservative Management with Gastrografin

2015

<b><i>Background:</i></b> Gastrografin represents a useful tool in the diagnosis and management of adhesive small bowel obstruction (ASBO). The aim of this study is to identify variables with negative influence in nonoperative management with gastrografin. <b><i>Methods:</i></b> From August 2008 to March 2013, 223 consecutive patients with 235 episodes of ASBO were included and received gastrografin. A protocol for prospective data collection was developed. In order to explore factors related to the failure of nonoperative treatment, univariate and multivariate analysis were performed. <b><i>Results:</i></b> One hundred…

AdultMalemedicine.medical_specialtyMultivariate analysisConservative managementClinical Decision-MakingGastrografinContrast MediaProspective dataTissue Adhesions030230 surgery03 medical and health sciencesPostoperative Complications0302 clinical medicineIntestine SmallmedicineHumansProspective StudiesAdhesive small bowel obstructionProspective cohort studyAgedDiatrizoate MeglumineAged 80 and overbusiness.industryGastroenterologyMiddle Agedmedicine.diseaseCombined Modality TherapySurgeryRadiographyBowel obstructionClinical trialTreatment Outcome030220 oncology & carcinogenesisCohortFemaleSurgerybusinessAdhesive syndromeIntestinal ObstructionPredictive factorsAbdominal surgery
researchProduct

Elevated levels of serum-soluble triggering receptor expressed on myeloid cells-1 in patients with IBD do not correlate with intestinal TREM-1 mRNA e…

2012

BACKGROUND AIMS Triggering receptor expressed on myeloid cells 1 (TREM 1) is a potent amplifier of pro inflammatory responses. We have previously demonstrated a substantial increase in TREM 1 expressing macrophages in the inflamed intestinal mucosa of patients with inflammatory bowel diseases (IBD). TREM 1 is also produced as a soluble receptor (sTREM 1). Here we aimed to determine whether serum sTREM 1 could be used as a surrogate marker of disease activity in patients with IBD. METHODS Intestinal biopsies and concurrently collected sera from patients with Crohn's disease (CD) and Ulcerative colitis (UC) enrolled in the Swiss IBD cohort study were analyzed for intestinal TREM 1 mRNA and se…

AdultMalemedicine.medical_specialtyMyeloidColonGastroenterologyInflammatory bowel diseaseEndoscopy GastrointestinalStatistics Nonparametric03 medical and health sciencesMice0302 clinical medicineIntestinal mucosaCrohn DiseaseIleumInternal medicinemedicineAnimalsHumansRNA MessengerColitisReceptors ImmunologicReceptor030304 developmental biology0303 health sciencesCrohn's diseaseMessenger RNAMembrane Glycoproteinsbusiness.industryGastroenterologyGeneral MedicineMiddle Agedmedicine.diseaseUlcerative colitisAdoptive Transferdigestive system diseasesTriggering Receptor Expressed on Myeloid Cells-13. Good healthmedicine.anatomical_structureROC CurveArea Under CurveImmunologyColitis UlcerativeFemalebusinessBiomarkers030215 immunologyJournal of Crohn's & colitis
researchProduct

Laparoscopic ileocecal resection in acute and chronic presentations of Crohn's disease. A single center experience

2017

Introduction The terminal ileum is the most involved tract in Crohn's disease. The obstruction in this location is the most frequent complication. Acute or chronic presentations can occur. Surgery finds a role in the management of chronic strictures and in acute clinical presentations with complications not improving with conservative therapy. Patients and methods We investigate the outcome of patients with obstruction of the ileo-cecal bowel tract laparoscopically managed. It was analyzed the average operative time (OT), the conversion rate and the occurrence of re-operation due to surgical complications. Results 21 patients underwent an ileocecal resection for complicated Crohn's disease …

AdultMalemedicine.medical_specialtyOperative TimeAnastomotic LeakAnastomosisClinical PracticeHospitals University03 medical and health sciencesIleocecal valve0302 clinical medicineCrohn DiseaseRisk FactorsRetrospective StudiemedicineHumansHemoperitoneumLaparoscopyRetrospective StudiesAcute Disease; Adult; Anastomosis Surgical; Anastomotic Leak; Chronic Disease; Conversion to Open Surgery; Crohn Disease; Female; Hospitals University; Humans; Ileal Diseases; Ileocecal Valve; Intestinal Obstruction; Length of Stay; Male; Operative Time; Retrospective Studies; Risk Factors; Treatment Outcome; LaparoscopyCrohn's diseaseIleocecal Valvemedicine.diagnostic_testbusiness.industryIleal DiseasesGeneral surgeryMortality rateRisk FactorAnastomosis SurgicalRetrospective cohort studyLength of Staymedicine.diseaseConversion to Open SurgerySurgerymedicine.anatomical_structureTreatment Outcome030220 oncology & carcinogenesisAcute DiseaseChronic DiseaseIleal Disease030211 gastroenterology & hepatologyFemaleLaparoscopymedicine.symptombusinessComplicationIntestinal ObstructionHuman
researchProduct

Assessing Somatic, Psychosocial, and Spiritual Distress of Patients with Advanced Cancer

2012

Objective: For adequate distress assessment in palliative care, we developed a screening evaluation tool. Methods: Proven methods of scale construction led to a 53-item pilot form of the Advanced Cancer Patients’ Distress Scale (ACPDS). We used Hornheide Questionnaire (HQ), Palliative Outcome Scale (POS), and Minimal Documentation System (MIDOS) for validation. Advanced cancer patients (N = 168) from 3 centers for palliative medicine (aged 23-89, 51% female) filled out the questionnaire. Results: With a principal component analysis (PCA), we extracted 5 distress scales (emotional reactions/physical restrictions, communication deficits, negative social reactions, pain, and gastrointestinal s…

AdultMalemedicine.medical_specialtyPalliative carePsychometricsGastrointestinal DiseasesPsychological interventionPainSpiritual distressYoung AdultGermanyNeoplasmsSickness Impact ProfileSurveys and QuestionnairesActivities of Daily LivingmedicineHumansTerminally IllPsychological testingSex DistributionAgedAged 80 and overbusiness.industryPalliative CareReproducibility of ResultsCancerGeneral MedicineMiddle Agedmedicine.diseaseDistressDyspneaScale (social sciences)Physical therapyFemalebusinessPsychosocialAmerican Journal of Hospice and Palliative Medicine®
researchProduct

A key role for abdominal ultrasound examination in "difficult" diagnoses of celiac disease.

2010

Purpose To evaluate the usefulness of abdominal ultrasound examination (US) for the diagnostic workup of cases of suspected CD involving negative serum antibodies and difficult diagnosis. Materials and methods 524 consecutive patients with symptoms of suspected CD underwent an extensive diagnostic workup. 76 (14 %) were excluded since they were positive for serum anti-tTG and/or EmA antibodies. 377 were excluded since they were diagnosed with something other than CD or did not have the alleles encoding for HLA DQ 2 or DQ 8. A diagnosis of CD with negative serum antibodies was probable in 71 patients who underwent abdominal US and duodenal biopsy for histology evaluation. Results Intestinal …

AdultMalemedicine.medical_specialtyPathologyAdolescentDuodenumBiopsyserologyspecificityDiseaseGastroenterologySensitivity and SpecificitySerologyYoung AdultSoftware DesignInternal medicineHLA-DQBiopsymedicineHumansRadiology Nuclear Medicine and imagingYoung adultMedical diagnosisIntestinal MucosaAutoantibodiesUltrasonographymedicine.diagnostic_testbusiness.industryultrasoundUltrasoundHistologyMiddle AgedsensitivityImmunoglobulin ACeliac DiseaseFemalebusinessUltraschall in der Medizin (Stuttgart, Germany : 1980)
researchProduct

Antiinflammatory treatment and intestinal alpha 1-antitrypsin clearance in active Crohn's disease.

1985

Intestinal alpha 1-antitrypsin clearance was quantified in 17 patients with clinically active Crohn's disease before and after a six-week period of treatment with sulfasalazine and methylprednisolone. Before the study, alpha 1-antitrypsin clearance and, hence, enteric protein loss was elevated as being above control values in 16 patients. After therapy, clearance values decreased in 11 and were normalized in five patients. Serum albumin level was normalized in 11 of 12 patients who had hypoalbuminemia before the study. Clinical condition was improved in all but 1 patient after treatment. There was no close correlation between alpha 1-antitrypsin clearance and disease activity index. These r…

AdultMalemedicine.medical_specialtyPathologyAdolescentPhysiologyProtein-Losing EnteropathiesSerum albuminAnti-Inflammatory AgentsGastroenterologyMethylprednisoloneFecesCrohn DiseaseSulfasalazineInternal medicinemedicineHumansHypoalbuminemiaIntestinal MucosaSerum AlbuminCrohn's diseasebiologybusiness.industryProtein losing enteropathyGastroenterologyAlbuminHepatologyMiddle Agedmedicine.diseasedigestive system diseasesSulfasalazineMethylprednisolonealpha 1-Antitrypsinbiology.proteinFemalebusinessmedicine.drugDigestive diseases and sciences
researchProduct

Aurora-A overexpression as an early marker of reflux-related columnar mucosa and Barrett's oesophagus.

2007

Abstract BACKGROUND: The development of oesophageal adenocarcinoma is generally closely associated with the presence of a specialised intestinal-type epithelium such as that found in Barrett's oesophagus (BO). A particular histological condition is when the distal oesophagus showing cardiac and/or fundic mucosa without intestinal metaplasia cannot be defined as 'Barrett's mucosa' [condition that we call 'columnar-lined oesophagus' (CLO)] and up till now, there has been no agreement in literature about the management of this condition. Aurora-A overexpression leads to centrosome amplification, chromosomal instability and aneuploidy in mammalian cells. PATIENTS AND METHODS: A prospective stud…

AdultMalemedicine.medical_specialtyPathologyEsophageal NeoplasmsSettore MED/06 - Oncologia MedicaAneuploidySettore BIO/11 - Biologia MolecolareAdenocarcinomaProtein Serine-Threonine KinasesSettore MED/08 - Anatomia PatologicaGastroenterologyBarrett EsophagusAurora KinasesInternal medicineBiopsymedicineHumansAurora-A overexpression Barrett’s oesophagus cell cycle columnar-lined oesophagus p53 proteinProspective StudiesEsophagusMucous Membranemedicine.diagnostic_testEsophageal diseasebusiness.industryIntestinal metaplasiaHematologyMiddle Agedmedicine.diseasemedicine.anatomical_structureOncologyDysplasiaBarrett's esophagusGastroesophageal RefluxFemalebusinessImmunostainingBiomarkers
researchProduct

Does Cytokeratin7/20 immunoreactivity help to distinguish Barrett's esophagus from gastric intestinal metaplasia? Results of a prospective study of 7…

2005

Barrett's esophagus is a recognized risk factor for the development of esophageal dysplasia and carcinoma. Unfortunately, gastric incomplete intestinal metaplasia arising in Short Segment Barrett's esophagus can be indistinguishable histologically on hematoxylin/eosin stains. Distinct patterns of CK 7 and CK 20 immunohistochemical expression have been demonstrated to be both highly sensitive and specific for Barrett's esophagus, but have not been found in gastric metaplasia. The aim of our study was to test whether immunostaining with CK 7/20 helps to distinguish between Barrett's epithelium and gastric incomplete metaplasia. Cases of long segment Barrett's esophagus, short segment Barrett'…

AdultMalemedicine.medical_specialtyPathologyH&E stainKeratin-20digestive systemGastroenterologyPathology and Forensic MedicineDiagnosis DifferentialBarrett EsophagusIntermediate Filament ProteinsPredictive Value of TestsInternal medicineMetaplasiaBiomarkers TumorPyloric AntrummedicineCarcinomaHumansProspective StudiesEsophagusneoplasmsMetaplasiabusiness.industryKeratin 20Keratin-7Intestinal metaplasiaCardiaCell BiologyMiddle Agedmedicine.diseasedigestive system diseasessurgical procedures operativemedicine.anatomical_structureBarrett's esophagusKeratin 7KeratinsFemalemedicine.symptombusinessPathology - Research and Practice
researchProduct

Anti-actin antibodies in celiac disease: correlation with intestinal mucosa damage and comparison of ELISA with the immunofluorescence assay.

2005

The presence in the sera of celiac disease (CD) patients of anti-actin autoantibodies (AAAs) has been suggested as a marker of severe intestinal villus atrophy (1). AAAs have been detected with an immunofluorescence (IF) technique and seem to contribute to villus cytoskeleton damage and to the pathogenesis of intestinal damage in CD (2). The aims of the present study were to evaluate the relationship between the presence of serum IgA AAAs and severity of intestinal mucosa damage in CD patients and to compare the IF assay with a new ELISA for IgA AAA determination. We enrolled 150 individuals in the study. IgA AAAs were assayed in 58 consecutive CD patients diagnosed between January and Dece…

AdultMalemedicine.medical_specialtyPathologySettore MED/09 - Medicina InternaAdolescentClinical Biochemistryanti-actin autoantibodieFluorescent Antibody TechniqueEnzyme-Linked Immunosorbent AssayAutoimmune hepatitisGastroenterologyCoeliac diseasePrimary biliary cirrhosisIntestinal mucosaInternal medicinemedicineHumansIntestinal MucosaChildPediatric gastroenterologyAutoantibodiesbusiness.industryBiochemistry (medical)Intestinal villusAutoantibodyInfantMiddle Agedmedicine.diseaseActinsImmunoglobulin AFood intoleranceanti-actin autoantibodies; celiac disease; ELISAmedicine.anatomical_structureChild PreschoolFemaleELISAbusinessceliac disease
researchProduct